Immunology
DNA vaccine targets human papillomavirus type 16 E6 or E7 oncoprotein
Published in Gene Therapy Weekly, August 26th, 2004
According to recent research from the United States, "DNA vaccines expressing the E6 or E7 oncoproteins of human papilloma virus type 16 (HPV-16) in either their wild-type form or fused to sequences that affect intracellular trafficking were tested for induction of protective immunity against tumor cell challenge in two models based on BALB/c and C57Bl/6 mice."
"The DNA vaccines to E7 gave uniformly disappointing results, while the DNA vaccine that expressed E6 linked to a viral leader sequence protected BALB/c mice against tumor cell challenge given before or after vaccination....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-08-26)
More Articles from Gene Therapy Weekly
- Congenital Disease
Lentiviral-mediated gene therapy corrects lysosomal storage disease in mice - Gastroenterology
NK4 gene transfer stops the dissemination of gallbladder cancer - Liver Cancer
Viral DNA recombination improves transgene expression in liver tumor cells - Restenosis
TIMP1 gene transfer prevents intimal hyperplasia in rodent arteries - Vector Development
Bacterial artificial chromosome systems yield high-titer recombinant virus - Antibody Development
Dyax licenses its antibody phage display libraries for antibody development - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
